Saturday, September 4, 2010

Are Flavor Metal Cores Good

Some symptoms of cancer in the U.S. recommend

Taken
EFE



  • Send this story Print


      • Washington, July 20 (Reuters) .- A committee of experts in the U.S. today advised the Food and Drug Agency (FDA) to withdraw from the market, Avastin (bevacizumab), used to treat breast cancer.
  • PHOTO AND VIDEO RELATED
    • Recommend U.S. medication withdrawal Avastin, used against breast cancer
Enlarge photo

RELATED NEWS
Increased risk of breast cancer by the use of cleaning products Barbacid opens a new possible avenue of treatment for lung cancer
Open a new way to treat lung cancer

investigate the role of 'heat shock proteins "in cancer
  • More News on Cancer
  • Forum: Cancer
  • Twelve of the thirteen experts on the committee voted against holding that the drug causes no improvement among patients with metastatic breast cancer and numerous other side effects. The committee's recommendation is not binding, although the FDA generally follows its advice.
The FDA approved the use of the drug, the Swiss drugmaker Roche in 2008, after a test will point extending up to five months the deadline for breast cancer worse.
Posted by admin at 7:11 AM

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)